# Electrically evoked mismatch negativity from speech stimuli as an objective measure of cochlear implant performance

## TL;DR

This study shows that mismatch negativity (MMN) can be used as an objective measure to assess how well cochlear implants help people process speech.

## Contribution

The study demonstrates that MMN responses correlate with speech perception performance in cochlear implant users, offering a new objective assessment method.

## Key findings

- CI users with lower word recognition scores had reduced MMN amplitudes and longer latencies.
- MMN responses correlated significantly with speech perception performance measured by WRS.
- MMN could serve as an objective tool for evaluating cochlear implant performance.

## Abstract

Cochlear implant (CI) success is often assessed using subjective tests like word recognition scores (WRS). However, these tests are unsuitable for children, non-native speakers, and individuals with cognitive impairments. Mismatch negativity (MMN), an objective measure of cortical auditory processing, offers a promising alternative for evaluating speech perception. This study aimed to assess speech perception in CI patients using MMN and examine its correlation with WRS.

The study included 23 ears from CI users fitted for at least six months. Speech stimuli were presented via direct audio input to the CI processor at 70 dB nHL using an MMN paradigm. The syllables ‘ba’ (standard) and ‘da’ (deviant) served as stimuli. MMN amplitude and latency were analyzed, and their correlation with WRS was examined.

A significant correlation was observed between WRS and MMN responses. CI users with lower WRS scores exhibited reduced MMN amplitudes and prolonged latencies compared to those with higher scores, indicating impaired cortical speech processing.

These findings suggest that speech-induced MMN could serve as an objective tool for assessing speech perception in CI users. MMN provides valuable insights for optimizing CI fitting, particularly for patients unable to undergo subjective testing. Integrating MMN into clinical practice could improve speech perception outcomes and enhance the quality of life for CI users.